Duplication of 8q24 in Chronic Lymphocytic Leukemia: Cytogenetic and Molecular Biologic Analysis of MYC Aberrations

• Eva Ondroušková,
• Michaela Bohúnová,
• Kristýna Závacká,
• Kristýna Závacká,
• Patrik Čech,
• Petra Šmuhařová,
• Miroslav Boudný,
• Miroslav Boudný,
• Martina Oršulová,
• Anna Panovská,
• Lenka Radová,
• Michael Doubek,
• Michael Doubek,
• Michael Doubek,
• Karla Plevová,
• Karla Plevová,
• Karla Plevová,
• Marie Jarošová

Affiliations

Eva Ondroušková

Department of Internal Medicine – Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia

Michaela Bohúnová

Department of Internal Medicine – Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia

Kristýna Závacká

Department of Internal Medicine – Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia

Kristýna Závacká

Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czechia

Patrik Čech

Department of Internal Medicine – Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia

Petra Šmuhařová

Department of Internal Medicine – Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia

Miroslav Boudný

Department of Internal Medicine – Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia

Miroslav Boudný

Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czechia

Martina Oršulová

Department of Internal Medicine – Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia

Anna Panovská

Department of Internal Medicine – Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia

Lenka Radová

Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czechia

Michael Doubek

Department of Internal Medicine – Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia

Michael Doubek

Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czechia

Michael Doubek

Institute of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University, Brno, Czechia

Karla Plevová

Department of Internal Medicine – Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia

Karla Plevová

Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czechia

Karla Plevová

Institute of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University, Brno, Czechia

Marie Jarošová

Department of Internal Medicine – Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia